T1 Gene 954 962 variants
T2 Condition 924 933 mutations
T3 Condition 434 449 BRCA1 mutations
T4 Biomarker 140 144 PrCa
T6 Condition 606 611 BRCA1
T8 Organism 1420 1423 men
T9 Biomarker 1248 1252 PrCa
T10 Condition 924 932 mutation
T11 Organism 78 81 men
T12 Biomarker 1412 1416 PrCa
T15 Condition 1212 1220 mutation
T16 Condition 291 311 female breast cancer
T17 Biomarker 1256 1266 âˆ¼3.75-fold
T19 Protein 734 738 gene
T20 Condition 1458 1463 BRCA1
T21 Gene 793 798 probe
T22 Organism 869 872 men
T23 Condition 1050 1058 mutation
T24 Protein 728 738 BRCA1 gene
T26 Condition 440 448 mutation
T27 Condition 11 26 Prostate cancer
T28 Condition 1445 1454 mutations
T29 Condition 434 439 BRCA1
T31 Condition 270 278 mutation
T32 Condition 1206 1220 BRCA1 mutation
T33 Condition 606 620 BRCA1 mutation
T34 Condition 264 278 BRCA1 mutation
T35 Biomarker 246 250 PrCa
T36 Biomarker 28 32 PrCa
T37 Condition 998 1003 BRCA1
T38 Condition 434 448 BRCA1 mutation
T40 Biomarker 453 457 PrCa
T41 Gene 707 720 coding region
T42 Condition 998 1012 BRCA1 mutation
T43 Organism 1553 1556 men
T44 Condition 1206 1211 BRCA1
T45 Condition 728 733 BRCA1
T46 Biomarker 1117 1121 PrCa
T47 Protein 499 503 gene
